SCHEMBL3757747

SCHEMBL3757747

CN(C(=O)O)C1CCN(C(=O)Cc2cccc(-c3c(N4CCOCC4)sc4c3CC(C)(C)CC4=O)c2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 2/20 0.35
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
RECQL P46063 1/20 0.34
KMT2A Q03164 1/20 0.34
AOC3 Q16853 8/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
FAAH O00519 1/20 0.33
NAAA Q02083 1/20 0.33
FFAR2 O15552 1/20 0.32
PRKDC P78527 1/20 0.32
CCR5 P51681 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759732 0.93 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL3762612 0.89 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL3763951 0.88 EPHX2 (0.37) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL3762145 0.88 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL3769096 0.87 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL3763755 0.85 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2LMNAMAPTGAA
Trifluoroacetic Acid SCHEMBL16161695 0.85 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL3758928 0.85 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2MAPTAOC3PIK3CA
SCHEMBL3756166 0.84 AOC3 (0.39) ALDH1A1SMN1; SMN2MAPTAOC3PIK3CA
SCHEMBL3759346 0.82 AOC3 (0.39) SMN1; SMN2AOC3PIK3CAPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA ALDH1A1 3061/4885SMN1; SMN2 1864/4885LMNA 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.